 David Bain
Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Progesterone | 17 | 2014 | 319 | 3.330 |
Why?
| | Thermodynamics | 19 | 2023 | 382 | 3.100 |
Why?
| | Promoter Regions, Genetic | 14 | 2015 | 1129 | 2.580 |
Why?
| | Receptors, Glucocorticoid | 6 | 2018 | 143 | 2.160 |
Why?
| | DNA | 10 | 2015 | 1358 | 1.850 |
Why?
| | Response Elements | 9 | 2018 | 83 | 1.530 |
Why?
| | Receptors, Steroid | 5 | 2015 | 52 | 1.530 |
Why?
| | Antibodies, Monoclonal | 3 | 2023 | 1262 | 1.420 |
Why?
| | Ultracentrifugation | 8 | 2018 | 48 | 1.130 |
Why?
| | Protein Binding | 13 | 2015 | 1919 | 0.930 |
Why?
| | Sodium Chloride | 5 | 2023 | 137 | 0.840 |
Why?
| | Protons | 1 | 2023 | 84 | 0.840 |
Why?
| | Gene Expression Regulation | 8 | 2015 | 2362 | 0.820 |
Why?
| | Binding Sites | 15 | 2018 | 1183 | 0.820 |
Why?
| | Estrogen Receptor alpha | 2 | 2014 | 120 | 0.810 |
Why?
| | Transcription, Genetic | 7 | 2014 | 1318 | 0.730 |
Why?
| | Protein Multimerization | 6 | 2021 | 160 | 0.720 |
Why?
| | Dynamic Light Scattering | 3 | 2023 | 7 | 0.570 |
Why?
| | Dimerization | 7 | 2012 | 177 | 0.510 |
Why?
| | Drug Industry | 1 | 2016 | 104 | 0.510 |
Why?
| | Receptors, Estrogen | 4 | 2015 | 372 | 0.510 |
Why?
| | Research Personnel | 1 | 2016 | 154 | 0.490 |
Why?
| | Teaching | 1 | 2016 | 226 | 0.470 |
Why?
| | Immunoglobulin G | 1 | 2018 | 782 | 0.460 |
Why?
| | Mammary Tumor Virus, Mouse | 2 | 2015 | 41 | 0.440 |
Why?
| | Protein Isoforms | 7 | 2012 | 339 | 0.420 |
Why?
| | Proteins | 2 | 2012 | 922 | 0.410 |
Why?
| | Receptors, Androgen | 1 | 2013 | 132 | 0.410 |
Why?
| | Protein Structure, Tertiary | 5 | 2016 | 804 | 0.370 |
Why?
| | Biomedical Research | 1 | 2016 | 590 | 0.370 |
Why?
| | DNA-Binding Proteins | 7 | 2014 | 1319 | 0.350 |
Why?
| | Potassium | 1 | 2010 | 128 | 0.340 |
Why?
| | Kinetics | 5 | 2015 | 1560 | 0.340 |
Why?
| | Sodium | 1 | 2010 | 182 | 0.330 |
Why?
| | Models, Molecular | 4 | 2018 | 1392 | 0.320 |
Why?
| | Protein Footprinting | 1 | 2008 | 9 | 0.310 |
Why?
| | DNA Footprinting | 3 | 2015 | 28 | 0.310 |
Why?
| | Deoxyribonucleases | 1 | 2008 | 21 | 0.310 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2007 | 195 | 0.280 |
Why?
| | Models, Biological | 3 | 2008 | 1647 | 0.270 |
Why?
| | Recombinant Proteins | 4 | 2016 | 1243 | 0.270 |
Why?
| | Transcription Factors | 3 | 2012 | 1531 | 0.260 |
Why?
| | Trans-Activators | 1 | 2007 | 369 | 0.250 |
Why?
| | Transcriptional Activation | 3 | 2012 | 341 | 0.240 |
Why?
| | Molecular Sequence Data | 6 | 2012 | 2793 | 0.240 |
Why?
| | Protein Conformation | 5 | 2009 | 823 | 0.230 |
Why?
| | Humans | 29 | 2018 | 115908 | 0.230 |
Why?
| | Long Interspersed Nucleotide Elements | 1 | 2003 | 26 | 0.220 |
Why?
| | Cytokines | 1 | 2011 | 1857 | 0.220 |
Why?
| | Base Sequence | 4 | 2012 | 2120 | 0.210 |
Why?
| | Xanthine Dehydrogenase | 1 | 2002 | 26 | 0.200 |
Why?
| | Xanthine Oxidase | 1 | 2002 | 72 | 0.200 |
Why?
| | Oxidoreductases | 1 | 2002 | 92 | 0.200 |
Why?
| | Viral Proteins | 2 | 2001 | 283 | 0.190 |
Why?
| | Allosteric Regulation | 3 | 2010 | 84 | 0.190 |
Why?
| | Static Electricity | 1 | 2021 | 117 | 0.180 |
Why?
| | Chemistry, Pharmaceutical | 1 | 2021 | 99 | 0.180 |
Why?
| | Biophysical Phenomena | 2 | 2015 | 63 | 0.180 |
Why?
| | Repressor Proteins | 5 | 2000 | 369 | 0.170 |
Why?
| | In Vitro Techniques | 2 | 2015 | 1044 | 0.160 |
Why?
| | Chromatography, Gel | 2 | 2017 | 128 | 0.150 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1998 | 313 | 0.150 |
Why?
| | Animals | 12 | 2018 | 32123 | 0.140 |
Why?
| | Protein Aggregates | 1 | 2017 | 66 | 0.140 |
Why?
| | Public-Private Sector Partnerships | 1 | 2016 | 43 | 0.140 |
Why?
| | Immunoglobulins, Intravenous | 1 | 2017 | 123 | 0.130 |
Why?
| | Luciferases | 2 | 2012 | 141 | 0.130 |
Why?
| | Structure-Activity Relationship | 2 | 2007 | 510 | 0.130 |
Why?
| | Transfection | 3 | 2012 | 866 | 0.120 |
Why?
| | NF-kappa B | 1 | 2018 | 639 | 0.120 |
Why?
| | Recombinant Fusion Proteins | 2 | 2015 | 616 | 0.110 |
Why?
| | Mutation, Missense | 1 | 2015 | 296 | 0.110 |
Why?
| | Hydrolysis | 2 | 2005 | 179 | 0.110 |
Why?
| | Molecular Weight | 2 | 2005 | 335 | 0.110 |
Why?
| | Cells, Cultured | 2 | 2012 | 3916 | 0.100 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 2012 | 45 | 0.100 |
Why?
| | Progestins | 1 | 2012 | 75 | 0.100 |
Why?
| | Evolution, Molecular | 1 | 2015 | 437 | 0.100 |
Why?
| | Hydrodynamics | 1 | 2011 | 34 | 0.100 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2007 | 513 | 0.090 |
Why?
| | Algorithms | 1 | 2018 | 1494 | 0.090 |
Why?
| | Breast Neoplasms | 3 | 2012 | 1870 | 0.090 |
Why?
| | Tamoxifen | 2 | 2000 | 192 | 0.090 |
Why?
| | Biological Phenomena | 1 | 2009 | 4 | 0.080 |
Why?
| | Tandem Repeat Sequences | 1 | 2008 | 18 | 0.080 |
Why?
| | Spodoptera | 1 | 2008 | 37 | 0.080 |
Why?
| | Binding, Competitive | 1 | 2008 | 200 | 0.080 |
Why?
| | DNA Fingerprinting | 1 | 2007 | 27 | 0.070 |
Why?
| | Substrate Specificity | 1 | 2008 | 357 | 0.070 |
Why?
| | Energy Metabolism | 1 | 2012 | 712 | 0.070 |
Why?
| | Allosteric Site | 1 | 2006 | 16 | 0.070 |
Why?
| | MicroRNAs | 1 | 2012 | 610 | 0.060 |
Why?
| | Salts | 1 | 2005 | 37 | 0.060 |
Why?
| | Solutions | 1 | 2005 | 150 | 0.060 |
Why?
| | Spectrometry, Fluorescence | 1 | 2005 | 158 | 0.060 |
Why?
| | Peptide Hydrolases | 1 | 2005 | 109 | 0.060 |
Why?
| | Protein Structure, Quaternary | 1 | 2003 | 115 | 0.060 |
Why?
| | Ligands | 1 | 2005 | 568 | 0.060 |
Why?
| | HeLa Cells | 3 | 2018 | 568 | 0.050 |
Why?
| | Microscopy, Atomic Force | 1 | 2003 | 116 | 0.050 |
Why?
| | Models, Genetic | 1 | 2006 | 585 | 0.050 |
Why?
| | Models, Statistical | 1 | 2007 | 616 | 0.050 |
Why?
| | Protein Processing, Post-Translational | 1 | 2005 | 400 | 0.050 |
Why?
| | Molecular Chaperones | 1 | 2003 | 157 | 0.050 |
Why?
| | Chromatography | 1 | 2002 | 24 | 0.050 |
Why?
| | Chymotrypsin | 1 | 2002 | 20 | 0.050 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 2002 | 100 | 0.050 |
Why?
| | Trypsin | 1 | 2002 | 67 | 0.050 |
Why?
| | Phenylalanine | 1 | 2002 | 58 | 0.050 |
Why?
| | Disulfides | 1 | 2002 | 91 | 0.050 |
Why?
| | Methionine | 1 | 2002 | 145 | 0.050 |
Why?
| | Mifepristone | 2 | 2000 | 65 | 0.050 |
Why?
| | Cross-Linking Reagents | 1 | 2002 | 182 | 0.050 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2001 | 75 | 0.050 |
Why?
| | Estrogen Receptor Modulators | 1 | 2000 | 17 | 0.050 |
Why?
| | Protein Denaturation | 1 | 2001 | 72 | 0.050 |
Why?
| | Cysteine | 1 | 2002 | 173 | 0.050 |
Why?
| | Circular Dichroism | 1 | 2001 | 135 | 0.050 |
Why?
| | Biophysics | 1 | 2001 | 70 | 0.050 |
Why?
| | Virus Assembly | 1 | 2001 | 67 | 0.050 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2002 | 477 | 0.040 |
Why?
| | Microscopy, Fluorescence | 1 | 2002 | 403 | 0.040 |
Why?
| | Lysine | 1 | 2002 | 243 | 0.040 |
Why?
| | Sulfhydryl Compounds | 1 | 2002 | 178 | 0.040 |
Why?
| | Endopeptidases | 1 | 2000 | 72 | 0.040 |
Why?
| | DNA Primers | 1 | 2001 | 513 | 0.040 |
Why?
| | Cattle | 1 | 2002 | 935 | 0.040 |
Why?
| | Hot Temperature | 1 | 2001 | 302 | 0.040 |
Why?
| | Protein Folding | 1 | 2000 | 242 | 0.040 |
Why?
| | Oxygen | 1 | 2002 | 839 | 0.040 |
Why?
| | Cold Temperature | 1 | 1998 | 127 | 0.040 |
Why?
| | Amino Acid Substitution | 1 | 2018 | 267 | 0.040 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2018 | 346 | 0.040 |
Why?
| | Ribosomal Proteins | 1 | 1997 | 70 | 0.040 |
Why?
| | Nuclear Proteins | 2 | 2000 | 594 | 0.030 |
Why?
| | Crystallography, X-Ray | 1 | 2018 | 409 | 0.030 |
Why?
| | Protein Stability | 1 | 2017 | 162 | 0.030 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2018 | 238 | 0.030 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2000 | 638 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 604 | 0.030 |
Why?
| | Centrifugation, Density Gradient | 1 | 1994 | 41 | 0.030 |
Why?
| | Potassium Chloride | 1 | 1994 | 35 | 0.030 |
Why?
| | Viral Regulatory and Accessory Proteins | 1 | 1994 | 25 | 0.030 |
Why?
| | Calibration | 1 | 2015 | 129 | 0.030 |
Why?
| | Bacteriophage lambda | 1 | 1994 | 81 | 0.030 |
Why?
| | Models, Chemical | 1 | 1994 | 264 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2018 | 1138 | 0.030 |
Why?
| | Operator Regions, Genetic | 1 | 1992 | 6 | 0.030 |
Why?
| | Deoxyribonucleases, Type II Site-Specific | 1 | 1992 | 17 | 0.030 |
Why?
| | Microarray Analysis | 1 | 2012 | 120 | 0.020 |
Why?
| | Time Factors | 1 | 2002 | 6186 | 0.020 |
Why?
| | 3' Untranslated Regions | 1 | 2012 | 137 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2012 | 260 | 0.020 |
Why?
| | COS Cells | 2 | 2003 | 176 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 1992 | 326 | 0.020 |
Why?
| | Protein Biosynthesis | 1 | 2012 | 389 | 0.020 |
Why?
| | Mice | 2 | 2003 | 15075 | 0.020 |
Why?
| | Nuclear Receptor Co-Repressor 2 | 2 | 2000 | 14 | 0.020 |
Why?
| | Nuclear Receptor Co-Repressor 1 | 2 | 2000 | 16 | 0.020 |
Why?
| | Male | 1 | 2013 | 56128 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2015 | 2814 | 0.020 |
Why?
| | Cell Movement | 1 | 2012 | 868 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2012 | 2749 | 0.020 |
Why?
| | Signal Transduction | 1 | 1996 | 4526 | 0.010 |
Why?
| | Mutagenesis | 1 | 2003 | 171 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2003 | 352 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2003 | 328 | 0.010 |
Why?
| | Nuclear Receptor Coactivator 1 | 1 | 2000 | 10 | 0.010 |
Why?
| | Histone Acetyltransferases | 1 | 2000 | 50 | 0.010 |
Why?
| | Drug Resistance | 1 | 2000 | 162 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2003 | 2000 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2003 | 675 | 0.010 |
Why?
| | Cell Division | 1 | 2000 | 760 | 0.010 |
Why?
| | Leucine Zippers | 1 | 1997 | 16 | 0.010 |
Why?
| | Yeasts | 1 | 1997 | 51 | 0.010 |
Why?
| | DNA, Complementary | 1 | 1997 | 262 | 0.010 |
Why?
| | Female | 3 | 2012 | 60086 | 0.010 |
Why?
| | DNA, Superhelical | 1 | 1992 | 11 | 0.010 |
Why?
| | Electrophoresis | 1 | 1992 | 25 | 0.010 |
Why?
| | Least-Squares Analysis | 1 | 1992 | 73 | 0.010 |
Why?
| | Plasmids | 1 | 1992 | 346 | 0.010 |
Why?
|
|
Bain's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|